Hyperandrogenism Clinical Trials

7 recruiting

Hyperandrogenism Trials at a Glance

7 actively recruiting trials for hyperandrogenism are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Early Phase 1 with 3 trials, with the heaviest enrollment activity in Charlottesville, Beijing, and Chaïdári. Lead sponsors running hyperandrogenism studies include University of Virginia, Attikon Hospital, and Guangzhou Women and Children's Medical Center.

Browse hyperandrogenism trials by phase

Treatments under study

About Hyperandrogenism Clinical Trials

Looking for clinical trials for Hyperandrogenism? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperandrogenism trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperandrogenism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOS

HyperinsulinismMetabolic SyndromePCOS+1 more
Attikon Hospital120 enrolled1 locationNCT06889454
Recruiting
Early Phase 1

Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

PubertyHyperandrogenism
University of Virginia36 enrolled1 locationNCT00929006
Recruiting
Early Phase 1

Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?

Polycystic Ovary SyndromePubertyHyperandrogenism
University of Virginia32 enrolled1 locationNCT04723862
Recruiting
Early Phase 1

Hyperandrogenemia and Altered Day-night LH Pulse Patterns

Polycystic Ovary SyndromePubertyHyperandrogenism
University of Virginia32 enrolled1 locationNCT03068910
Recruiting
Phase 2

Acupuncture or Metformin for Insulin Resistance in Women With PCOS

Insulin ResistancePolycystic Ovary SyndromeHyperandrogenism
Karolinska Institutet303 enrolled2 locationsNCT02647827
Recruiting

FEmale Metabolic Risk and Androgens: an Irish Longitudinal (FEMAIL) Study

Metabolic DiseaseHyperandrogenismSex Hormones Adverse Reaction
Royal College of Surgeons, Ireland500 enrolled1 locationNCT04912648
Recruiting

Offspring Born to Mothers With Polycystic Ovary Syndrome in Guangzhou Cohort Study

Metabolic DisturbanceInsulin ResistanceEpigenetics+4 more
Guangzhou Women and Children's Medical Center2,000 enrolled1 locationNCT03742011